Logo image of ICAD.PA

ICADE (ICAD.PA) Stock Fundamental Analysis

Europe - EPA:ICAD - FR0000035081 - REIT

20.76 EUR
-0.1 (-0.48%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, ICAD scores 3 out of 10 in our fundamental rating. ICAD was compared to 42 industry peers in the Diversified REITs industry. Both the profitability and financial health of ICAD have multiple concerns. ICAD has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ICAD had positive earnings in the past year.
ICAD had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ICAD reported negative net income in multiple years.
ICAD had a positive operating cash flow in each of the past 5 years.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

With a Return On Assets value of -1.85%, ICAD is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
ICAD's Return On Equity of -4.79% is on the low side compared to the rest of the industry. ICAD is outperformed by 80.95% of its industry peers.
ICAD has a Return On Invested Capital of 2.76%. This is in the lower half of the industry: ICAD underperforms 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ICAD is in line with the industry average of 3.38%.
The 3 year average ROIC (2.14%) for ICAD is below the current ROIC(2.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.85%
ROE -4.79%
ROIC 2.76%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

Looking at the Operating Margin, with a value of 19.60%, ICAD is doing worse than 83.33% of the companies in the same industry.
ICAD's Operating Margin has declined in the last couple of years.
ICAD does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 19.6%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICAD is destroying value.
Compared to 1 year ago, ICAD has about the same amount of shares outstanding.
Compared to 5 years ago, ICAD has more shares outstanding
Compared to 1 year ago, ICAD has a worse debt to assets ratio.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.64, we must say that ICAD is in the distress zone and has some risk of bankruptcy.
ICAD's Altman-Z score of 0.64 is on the low side compared to the rest of the industry. ICAD is outperformed by 64.29% of its industry peers.
The Debt to FCF ratio of ICAD is 45.49, which is on the high side as it means it would take ICAD, 45.49 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 45.49, ICAD is doing worse than 78.57% of the companies in the same industry.
ICAD has a Debt/Equity ratio of 0.97. This is a neutral value indicating ICAD is somewhat dependend on debt financing.
The Debt to Equity ratio of ICAD (0.97) is worse than 73.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.49
Altman-Z 0.64
ROIC/WACC1
WACC2.77%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.06 indicates that ICAD should not have too much problems paying its short term obligations.
The Current ratio of ICAD (1.06) is better than 73.81% of its industry peers.
ICAD has a Quick Ratio of 1.06. This is a bad value and indicates that ICAD is not financially healthy enough and could expect problems in meeting its short term obligations.
ICAD's Quick ratio of 0.81 is fine compared to the rest of the industry. ICAD outperforms 73.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.81
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1

3. Growth

3.1 Past

ICAD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -72.25%.
The Earnings Per Share has been decreasing by -9.69% on average over the past years.
The Revenue for ICAD has decreased by -13.82% in the past year. This is quite bad
The Revenue has been growing slightly by 0.64% on average over the past years.
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%

3.2 Future

Based on estimates for the next years, ICAD will show a decrease in Earnings Per Share. The EPS will decrease by -1.45% on average per year.
Based on estimates for the next years, ICAD will show a decrease in Revenue. The Revenue will decrease by -1.36% on average per year.
EPS Next Y10.58%
EPS Next 2Y2.48%
EPS Next 3Y-1.45%
EPS Next 5YN/A
Revenue Next Year-6.62%
Revenue Next 2Y-1.93%
Revenue Next 3Y-1.36%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.97, which indicates a rather cheap valuation of ICAD.
Compared to the rest of the industry, the Price/Earnings ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 95.24% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, ICAD is valued rather cheaply.
The Price/Forward Earnings ratio is 6.25, which indicates a rather cheap valuation of ICAD.
97.62% of the companies in the same industry are more expensive than ICAD, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ICAD to the average of the S&P500 Index (22.73), we can say ICAD is valued rather cheaply.
Industry RankSector Rank
PE 6.97
Fwd PE 6.25
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICAD indicates a rather cheap valuation: ICAD is cheaper than 95.24% of the companies listed in the same industry.
ICAD's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 15.39
EV/EBITDA 10.44
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2Y2.48%
EPS Next 3Y-1.45%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.56%, ICAD is a good candidate for dividend investing.
ICAD's Dividend Yield is comparable with the industry average which is at 5.44.
Compared to an average S&P500 Dividend Yield of 2.41, ICAD pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.56%

5.2 History

The dividend of ICAD has a limited annual growth rate of 1.04%.
Dividend Growth(5Y)1.04%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

The earnings of ICAD are negative and hence is the payout ratio. ICAD will probably not be able to sustain this dividend level.
DP-185.46%
EPS Next 2Y2.48%
EPS Next 3Y-1.45%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

ICADE

EPA:ICAD (9/12/2025, 7:00:00 PM)

20.76

-0.1 (-0.48%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-23 2025-07-23/amc
Earnings (Next)10-20 2025-10-20
Inst Owners72.7%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.58B
Analysts69.47
Price Target24.85 (19.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.56%
Yearly Dividend4.84
Dividend Growth(5Y)1.04%
DP-185.46%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.35%
PT rev (3m)-3.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)3.21%
EPS NY rev (3m)3.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.55%
Revenue NY rev (3m)2.31%
Valuation
Industry RankSector Rank
PE 6.97
Fwd PE 6.25
P/S 1.06
P/FCF 15.39
P/OCF 4.82
P/B 0.41
P/tB 0.41
EV/EBITDA 10.44
EPS(TTM)2.98
EY14.35%
EPS(NY)3.32
Fwd EY15.99%
FCF(TTM)1.35
FCFY6.5%
OCF(TTM)4.31
OCFY20.75%
SpS19.67
BVpS51.19
TBVpS50.76
PEG (NY)0.66
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.85%
ROE -4.79%
ROCE 3.87%
ROIC 2.76%
ROICexc 3.38%
ROICexgc 3.4%
OM 19.6%
PM (TTM) N/A
GM N/A
FCFM 6.86%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ROICexc(3y)2.49%
ROICexc(5y)2.67%
ROICexgc(3y)2.5%
ROICexgc(5y)2.68%
ROCE(3y)3.06%
ROCE(5y)3.38%
ROICexcg growth 3Y-8.78%
ROICexcg growth 5Y2.92%
ROICexc growth 3Y-8.79%
ROICexc growth 5Y2.96%
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.49
Debt/EBITDA 9.41
Cap/Depr 211.04%
Cap/Sales 15.05%
Interest Coverage 4.1
Cash Conversion 81.96%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.81
Altman-Z 0.64
F-Score5
WACC2.77%
ROIC/WACC1
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
EPS Next Y10.58%
EPS Next 2Y2.48%
EPS Next 3Y-1.45%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%
Revenue Next Year-6.62%
Revenue Next 2Y-1.93%
Revenue Next 3Y-1.36%
Revenue Next 5YN/A
EBIT growth 1Y74.88%
EBIT growth 3Y-29.53%
EBIT growth 5Y-3.23%
EBIT Next Year45.89%
EBIT Next 3Y14.53%
EBIT Next 5Y8.67%
FCF growth 1Y240.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.57%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%